Patent | Date |
---|
Inhibitors Of Kras G12c And Methods Of Using The Same App 20220213101 - LANMAN; Brian Alan ;   et al. | 2022-07-07 |
Kras G12c Inhibitors And Methods Of Using The Same App 20220175782 - ALLEN; John Gordon ;   et al. | 2022-06-09 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ;   et al. | 2022-06-02 |
Inhibitors of KRAS G12C and methods of using the same Grant 11,306,087 - Lanman , et al. April 19, 2 | 2022-04-19 |
Substituted piperazines as KRAS G12C inhibitors Grant 11,285,156 - Allen , et al. March 29, 2 | 2022-03-29 |
Macrocyclic compounds that inhibit MCL-1 protein Grant 11,279,712 - Brown , et al. March 22, 2 | 2022-03-22 |
Compounds that inhibits MCL-1 protein Grant 11,224,601 - Harrington , et al. January 18, 2 | 2022-01-18 |
KRAS G12C inhibitors and methods of using the same Grant 11,090,304 - Allen , et al. August 17, 2 | 2021-08-17 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ;   et al. | 2021-06-17 |
Heterocyclic Compounds As Delta-5 Desaturase Inhibitors And Methods Of Use App 20210171529 - ALLEN; Jennifer R. ;   et al. | 2021-06-10 |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use Grant 10,889,581 - Allen , et al. January 12, 2 | 2021-01-12 |
Compounds that inhibit Mcl-1 protein Grant 10,821,115 - Harrington , et al. November 3, 2 | 2020-11-03 |
Macrocyclic Compounds That Inhibit Mcl-1 Protein App 20200247821 - Kind Code | 2020-08-06 |
Cyclopropyl Fused Thiazine Derivatives As Beta-secretase Inhibitors And Methods Of Use App 20200231585 - ALLEN; Jennifer R. ;   et al. | 2020-07-23 |
Inhibitors Of Kras G12c And Methods Of Using The Same App 20200207766 - LANMAN; Brian Alan ;   et al. | 2020-07-02 |
Compounds That Inhibit Mcl-1 Protein App 20200171043 - HARRINGTON; Paul E. ;   et al. | 2020-06-04 |
Inhibitors of KRAS G12C and methods of using the same Grant 10,640,504 - Lanman , et al. | 2020-05-05 |
Compounds that inhibit Mcl-1 protein Grant 10,632,128 - Harrington , et al. | 2020-04-28 |
Compounds That Inhibit Mcl-1 Protein App 20190381064 - HARRINGTON; Paul E. ;   et al. | 2019-12-19 |
Kras G12c Inhibitors And Methods Of Using The Same App 20190374542 - ALLEN; John Gordon ;   et al. | 2019-12-12 |
Kras G12c Inhibitors And Methods Of Using The Same App 20190343838 - Allen; John Gordon ;   et al. | 2019-11-14 |
Inhibitors Of Kras G12c And Methods Of Using The Same App 20190077801 - LANMAN; Brian Alan ;   et al. | 2019-03-14 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ;   et al. | 2019-02-28 |
Compounds That Inhibit Mcl-1 Protein App 20180289720 - Harrington; Paul E. ;   et al. | 2018-10-11 |
Cyclopropyl Fused Thiazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20170267673 - ALLEN; Jennifer R. ;   et al. | 2017-09-21 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ;   et al. | 2017-05-25 |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,611,261 - Minatti , et al. April 4, 2 | 2017-04-04 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,550,762 - Allen , et al. January 24, 2 | 2017-01-24 |
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20160280695 - MINATTI; Ana Elena ;   et al. | 2016-09-29 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ;   et al. | 2016-05-19 |
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,296,734 - Minatti , et al. March 29, 2 | 2016-03-29 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of Use App 20160046618 - ALLEN; Jennifer R. ;   et al. | 2016-02-18 |
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20150252011 - Minatti; Ana Elena ;   et al. | 2015-09-10 |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,085,576 - Minatti , et al. July 21, 2 | 2015-07-21 |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Grant 9,012,446 - Chen , et al. April 21, 2 | 2015-04-21 |
Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use Grant 8,957,083 - Minatti , et al. February 17, 2 | 2015-02-17 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ;   et al. | 2014-10-23 |
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20140275058 - MINATTI; Ana Elena ;   et al. | 2014-09-18 |
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20140249104 - MINATTI; Ana Elena ;   et al. | 2014-09-04 |
Amino-oxazines And Amino-dihydrothiazine Compounds As Beta-secretase Modulators And Methods Of Use App 20140045828 - CHEN; Jian ;   et al. | 2014-02-13 |
Spiro-Amino-Imidazolone and Spiro-Amino-Dihydro-Pyrimidinone Compounds as Beta-Secretase Modulators and Methods of Use App 20130338177 - Minatti; Ana Elena ;   et al. | 2013-12-19 |